L-Norvaline methyl ester hydrochloride

L-Norvaline methyl ester hydrochloride is the hydrochloride salt of the methyl ester of L-norvaline, a chiral aliphatic amino acid derivative bearing an (S)-configured stereocenter at the alpha-carbon. The molecule combines a methyl ester at the carboxyl terminus with an amino group present as a protonated chloride salt, which influences solubility and handling while maintaining a well-defined functional-group pattern for downstream transformations. The side chain is a straight-chain propyl substituent that can participate in hydrophobic interactions during peptide and peptidomimetic assembly and can serve as a handle for further derivatization. The ester functionality supports peptide coupling chemistry after conversion to a carboxyl-activated form or after controlled hydrolysis, while the salt-form amino group is compatible with standard N-protection strategies used in protected amino acid synthesis.

1. Peptide Synthesis

L-Norvaline methyl ester hydrochloride is applied in peptide building-block preparation where the alpha-amino functionality and ester-protected carboxyl group enable controlled conversion into coupling-ready forms. The chiral backbone supports stereochemically consistent incorporation of L-norvaline into linear peptides, and the ester can be transformed to an activated carboxyl derivative or adjusted through hydrolysis to match the coupling strategy. N-protection of the amino group following salt formation can be used to generate an N-protected norvaline methyl ester intermediate that aligns with common peptide coupling workflows. Resulting norvaline-containing peptides and peptide fragments can be used for structure-activity relationship studies, sequence optimization, and synthetic library construction in amino acid chemistry.

2. Chiral Amino Acid Intermediate

L-Norvaline methyl ester hydrochloride functions as a chiral amino acid intermediate for stereoselective synthesis of norvaline-derived derivatives where preservation of the L-configuration is required. The combination of a stereogenic center, an amino group (as the hydrochloride salt), and a methyl ester provides a practical platform for installing orthogonal protecting groups and for directing chemoselective transformations at the side chain or carboxyl terminus. Ester-to-acid conversion and subsequent re-esterification or activation can be employed to access downstream intermediates used in fine chemical synthesis and peptide precursor manufacture. The resulting chiral intermediates can then be carried into peptide analog construction, chiral scaffold diversification, and process-oriented preparation of amino acid derivatives.

3. Side-Chain Functionalization

L-Norvaline methyl ester hydrochloride is suitable for side-chain functionalization workflows in which the unbranched propyl substituent allows controlled introduction of additional reactive motifs while maintaining the amino acid stereochemical framework. The methyl ester and salt-form amino group can be managed through protection/deprotection sequences to enable selective chemistry on the side chain without uncontrolled reactivity at the termini. Derivatization routes that convert the ester to alternative carboxyl derivatives or that temporarily mask the amine can facilitate downstream formation of functionalized norvaline analogs used in peptidomimetics and molecular design. Functionalized products can serve as intermediates for generating hydrophobic or sterically tuned residues that influence conformational preferences in peptide science.

4. Pharmaceutical Intermediate Preparation

L-Norvaline methyl ester hydrochloride is employed in pharmaceutical intermediate preparation where amino acid-derived fragments are incorporated into larger synthetic targets through robust amide or ester-forming steps. The protected carboxyl equivalent (methyl ester) and amino functionality enable conversion into activated carboxylates or amide-forming intermediates after appropriate protecting-group adjustments, supporting scalable route design for substituted norvaline derivatives. The hydrochloride salt form can improve handling and reproducibility during intermediate synthesis, while the L-stereocenter supports consistent stereochemical outcomes in downstream coupling. Norvaline-containing intermediates prepared from this compound can be used to build peptidomimetic scaffolds and other nitrogen-containing fragments relevant to industrial fine chemical production.

5. Analytical Standards And Labeling

L-Norvaline methyl ester hydrochloride can be used for analytical research and method development where a defined chiral amino acid ester is required as a reference material or derivatization substrate. The presence of a stable methyl ester and the amino acid stereocenter supports chromatographic identification and can be adapted for conversion into standards that reflect specific protection states used in peptide chemistry. Controlled hydrolysis or conversion to other functional forms can enable generation of analytical comparators for norvaline-containing peptides, amino acid ester profiles, and intermediate monitoring in synthetic sequences. The compound's defined structure also makes it suitable as a starting point for isotopic labeling strategies in biochemical research intermediate preparation, supporting traceable quantification of norvaline incorporation.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L